| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |